Update of PSMA Theranostics in Prostate Cancer: Current Applications and Future Trends
There is now an increasing trend for targeting cancers to go beyond early diagnosis and actually improve Progression-Free Survival and Overall Survival. Identifying patients who might benefit from a particular targeted treatment is the main focus for Precision Medicine. Radiolabeled ligands can be u...
Saved in:
Main Authors: | Chalermrat Kaewput, Sobhan Vinjamuri |
---|---|
Other Authors: | Siriraj Hospital |
Format: | Review |
Published: |
2022
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/74559 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Update of PSMA Theranostics in Prostate Cancer: Current Applications and Future Trends
by: Kaewput C.
Published: (2023) -
Comparison of renal uptake of <sup>68</sup>Ga-DOTANOC PET/CT and estimated glomerular filtration rate before and after peptide receptor radionuclide therapy in patients with metastatic neuroendocrine tumours
by: Chalermrat Kaewput, et al.
Published: (2018) -
Role of Combined<sup>68</sup>Ga DOTA-Peptides and<sup>18</sup>F FDG PET/CT in the Evaluation of Gastroenteropancreatic Neuroendocrine Neoplasms
by: Chalermrat Kaewput, et al.
Published: (2022) -
Current update on theranostic roles of cyclophilin A in kidney diseases
by: Sudarat Hadpech, et al.
Published: (2022) -
Patient dosimetry of <sup>177</sup>Lu-PSMA I&T in metastatic prostate cancer treatment: the experience in Thailand
by: Kotchakorn Chatachot, et al.
Published: (2022)